Orexo strengthens its sustainability work by establishing a social financing framework

BY PR Newswire | CORPORATE | 03/08/24 02:24 AM EST

UPPSALA, Sweden, March 8, 2024 /PRNewswire/?--?Orexo AB (publ), ('Orexo (ORXOF)' or the 'Company') (STO: ORX) today announces that the Company has established a social financing framework dated February 2024 (the 'Social Framework'), which enables Orexo (ORXOF) to issue social bonds and potentially raise social loans, as well as other type of debt instruments (together the 'Social Financing Instruments'). The proceeds from any Social Financing Instrument will be used to finance and refinance, in whole or in part, future projects aimed at improving access to healthcare services for the treatment of substance use disorders and other related mental health issues, which are expected to deliver positive social impacts.

Nikolaj S?rensen, President and CEO of Orexo (ORXOF), said, "The social framework is the result of several years of systematic and thoughtful sustainability work and is fully aligned with our strategy to contribute to a more sustainable society for all. At the heart of this important work is improving the lives of those suffering from opioid dependence with pioneering and holistic treatment solutions. The social framework allows us to continue investing in social projects focusing on a stigmatized and underserved patient group."

Proceeds from any Social Financing Instruments are fully dedicated to the financing of projects with a positive social impact and expected to help advance the following SDG and targets, as further described in the Social Framework:

Use of Proceeds Category

UN Sustainable Development Goal

SDG target

Access to Essential Services

3. Good Health and


3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Morningstar Sustainalytics has conducted an independent review of the Social Framework and concludes it to be aligned with ICMA's (International Capital Market Association) Social Bond Principles 2023 and the APLMA (Asia Pacific Loan Market Association)/LMA (Loan Market Association)/LSTA's (Loan Syndications and Trading Association) Social Loan Principles 2023 (the 'Second Opinion'). Additionally, Sustainalytics considers the Social Framework to be credible, impactful and to be aligned with the overall sustainability strategy of the Company and that the use of proceeds category will contribute to the advancement of UN Sustainable Development Goal 3 ? Good Health and Wellbeing.

The Social Framework and the Second Opinion are available on Orexos's website under the heading ESG Sustainable investing and Orexo (ORXOF) intends to regularly report on the underlying social eligible projects which will be published on the Company's website.

ABG Sundal Collier AB and Carnegie Investment Bank have acted structuring advisors in connection to the establishment of the Social Framework.

As announced today in a separate press release, Orexo (ORXOF) contemplates to issue new senior secured callable floating rate social bonds under the Social Framework.

For further information please contact:
Nikolaj S?rensen, President and CEO
Fredrik J?rrsten, EVP and CFO
Lena Wange, IR & Communications Director

Tel: +46 (0)18?780 88 00
E-mail: ir@orexo.com ?

About Orexo (ORXOF)
Orexo (ORXOF) is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo (ORXOF) provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo (ORXOF) is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

For more information about Orexo (ORXOF) please visit www.orexo.com.? You can also follow Orexo (ORXOF) on X, LinkedIn, and YouTube.

Morningstar Sustainalytics, a globally-recognized provider of ESG research, ratings and data, evaluated Orexo's (ORXOF) Framework and the alignment thereof with relevant industry standards and provided views on the robustness and credibility of the Framework. In no event shall the Social Financing Framework nor any portion thereof be construed as part of the offering, nor shall be considered as an offer or advertisement to buy a security, solicitation of votes or proxies, investment advice, expert opinion or negative assurance letter as defined by the applicable legislation.

The information was sent for publication, through the agency of the contact person set out above, on March 8, 2024, at 8 CET.

This information was brought to you by Cision http://news.cision.com


The following files are available for download:


Orexo_PR_Orexo strengthens its sustainability work by establishing a social financing framework _Publ_March 8 2024


Cision View original content:https://www.prnewswire.com/news-releases/orexo-strengthens-its-sustainability-work-by-establishing-a-social-financing-framework-302083864.html


In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.